Log In
Thursday 22nd March 2018

Ovarian cancer drugs to be developed

18th August 2010

British and American researchers funded in part by Cancer Research UK believe they may have taken a step forward in the fight against ovarian cancer.

The researchers have identified a key protein they think could lead to new drugs being developed to hit ovarian cancer. At present chemotherapy drugs are prescribed to shrink ovarian tumours by stopping cancer cells dividing but some ovarian cancers are resistant. The research team found that cells struggled to divide when they interfered with a gene known as SIK2, which produces the protein.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018